RANKINGS
Key list: leading companies globally by R&D expenditure
Powered by
This month our pharma industry key list brings you the 15 leading companies globally by R&D expenditure, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of February 2021.
| Company name | Headquarters location | Number of employees | R&D expenditure ($m) |
F. Hoffmann-La Roche Ltd | Switzerland | 97,735 | 11,768 |
Johnson & Johnson | US | 132,200 | 11,355 |
Merck & Co Inc | US | 71,000 | 9,696 |
Gilead Sciences Inc | US | 11,800 | 8,934 |
Novartis AG | Switzerland | 103,914 | 8,386 |
Pfizer Inc | US | 88,300 | 7,984 |
Sanofi | France | 100,409 | 7,098 |
Bayer AG | Germany | 104,711 | 5,981 |
Bristol-Myers Squibb Co | US | 30,000 | 5,845 |
Eli Lilly and Co | US | 33,625 | 5,595 |
GlaxoSmithKline Plc | UK | 99,437 | 5,537 |
AbbVie Inc | US | 30,000 | 5,407 |
AstraZeneca Plc | UK | 70,600 | 5,320 |
Amgen Inc | US | 23,400 | 4,116 |
Takeda Pharmaceutical Co Ltd | Japan | 49,578 | 3,388 |
